Anteris CEO to Present at TD Cowen and Barclays Healthcare Conferences
Event summary
- Anteris CEO Wayne Paterson to present at TD Cowen and Barclays healthcare conferences in March 2026.
- TD Cowen presentation scheduled for March 2nd, 2026, featuring a fireside chat with analyst Joshua Jennings.
- Barclays presentation scheduled for March 10th, 2026, featuring a fireside chat with analyst Matt Miksic.
- Webcasts available via Anteris' Investor Center, with replays archived for 90 days.
The big picture
Anteris' participation in high-profile healthcare investor conferences underscores its strategic push to strengthen market positioning amid growing competition in the structural heart disease space. The presentations come at a critical juncture as the company seeks to differentiate its DurAVR THV technology, which aims to replicate normal aortic blood flow. Investors will be watching closely for insights into Anteris' commercialization strategy and its ability to navigate regulatory and competitive challenges.
What we're watching
- Market Positioning
- How Anteris' presentations will impact investor perception of its structural heart solutions.
- Product Differentiation
- Whether the DurAVR THV's biomimetic design will be highlighted as a key competitive advantage.
- Execution Risk
- The pace at which Anteris can scale its commercialization efforts post-presentations.
Our editorial coverage:
Related topics